Our Centres strong performances in Research Excellence Framework

1 min read

Brain Tumour Research is congratulating its Centres of Excellence on great performances in the latest Research Excellence Framework (REF).

The results of the UK-wide assessment of university research were published last week. This is an important review as the results of the REF will be used to guide distribution of research funding across the UK, the value of which will stand at around £2 billion from 2022-23.

In this national audit of research, all staff with a “significant responsibility” for research were entered for assessment.

Imperial College London, the host university for one of our Centres of Excellence, led by Kevin O’Neill and Dr Nel Syed (pictured left, with our Director of Research, Policy and Innovation, Dr Karen Noble), was ranked at the top amongst universities in the UK. The Department of Brain Sciences, in which our Centre is based, also scored top, when compared to other units researching Psychology, Psychiatry and Neuroscience.

Good news from Queen Mary University of London too, where our Centre, headed by Professor Silvia Marino, is located. In clinical medicine, 90% of the research was rated as world-leading or internationally excellent, and in the top ten for research power.

The University of Plymouth, home to our Centre directed by Professor Oliver Hanemann, also had cause to celebrate with 78% of their submission assessed as world-leading or internationally excellent.

Well done to our Centres and the researchers funded by Brain Tumour Research. We are proud of you and the game-changing research that you are undertaking. It is great to see your achievements recognised nationally.

Related reading:

If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.

Back to Research & Campaigning News